Risk Factors for Infection in Patient with Myelofibrosis

Purpose: To identify a patient with primary myelofibrosis who is at risk for infection based on the study of Polverelli et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with primary myelofibrosis?

Yes

Was baseline IPSS intermediate-2 or high risk?

Yes

Vertical breadth of spleen below the left costal margin

Is the patient being treated with ruxolitinib?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for infection over time

The patient has a

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Other Testing
- MIPSS70+ Version 2.0 for Evaluating Patient with Primary Myelofibrosis
Severity, Prognosis, Stage
- Lille Scoring System for Predicting Survival in Agnogenic Myeloid Metaplasia
- Dynamic International Prognostic Scoring System (DIPSS) of Passamonti et al for Predicting Survival in Primary Myelofibrosis

Therapy

Options
- Lille Scoring System for Predicting Survival in Agnogenic Myeloid Metaplasia
Selection
- MIPSS70+ Version 2.0 for Evaluating Patient with Primary Myelofibrosis

Monitoring

Response To Therapy
- Lille Scoring System for Predicting Survival in Agnogenic Myeloid Metaplasia

Specialty

Hematology Oncology

Objective

risk factors
complications

ICD-10

C94.4 - Acute panmyelosis with myelofibrosis
D47.4 - Osteomyelofibrosis

Info

Purpose: To identify a patient with primary myelofibrosis who is at risk for infection based on the study of Polverelli et al.

Specialty: Hematology Oncology

Objective: risk factors, complications

ICD-10: C94.4, D47.4,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path